For PD, lentivirus-mediated GRN gene delivery has been reported to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neuronal loss and locomotor deficits [254]. The gene discussed is GRN; the disease is Parkinson disease.